Novavax's (NVAX) updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- ...
(RTTNews) - Novavax (NVAX) has filed for authorization with Health Canada for 2024-2025 Formula COVID-19 vaccine or NVX-CoV2705 for individuals aged 12 and older. Novavax plans to have its vaccine ...
Investigative Journalism Foundation on MSN
No good option: These Canadians want to be protected against COVID but are unhappy with the choice of vaccines this fall
The federal government has decided against procuring a protein-based COVID-19 vaccine for the fall immunization campaign — ...
GAITHERSBURG, Md., Nov. 18, 2022 /PRNewswire/ -- Novavax, Inc. (NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, ...
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica was a writer on the Wellness team, with a focus on health ...
Novavax on Thursday provided preliminary adjusted revenue for 2026 and pushed back its profitability target by a year to 2028 ...
TipRanks on MSN
Novavax’s Q3 2025 Earnings Call: Optimistic Outlook
Novavax (($NVAX)) has held its Q3 earnings call. Read on for the main highlights of the call. Novavax’s Q3 2025 Earnings Call: A Cautiously ...
NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback